Skip to main content
. Author manuscript; available in PMC: 2012 Jul 22.
Published in final edited form as: J Mol Neurosci. 2011 May 10;45(3):372–378. doi: 10.1007/s12031-011-9533-3

Figure 2.

Figure 2

Regions of grey matter loss that were different between the bvFTD subjects with PiD, CBD or FTLD-TDP type 1 pathology. The top panel shows regions of greater loss in PiD compared to CBD; the middle panel shows regions of greater loss in FTLD-TDP type 1 compared to CBD; and the bottom panel shows regions of greater loss in FTLD-TDP type 1 compared to PiD. Results are shown uncorrected for multiple comparisons at p<0.001 on medial and lateral three dimensional renderings of the brain.